Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analysesHongchao Pan, Ligita Jančorienė, Richárd Pető et al.|The Lancet|2022Cited by 407
Letter to the editor: Importance of universal screening for chronic hepatitis B infection in adults in the United StatesChari Cohen, Samuel So, Mehlika Toy et al.|Hepatology|2021Cited by 6
Cost-Effectiveness Analysis of Fourth- or Further-Line Ripretinib in Advanced Gastrointestinal Stromal TumorsWei‐Ting Liao, Qiu Li, Huiqiong Xu et al.|Frontiers in Oncology|2021Cited by 1